EKF Diagnostics Holdings plc
EKDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $50,194 | $52,611 | $66,635 | $81,836 |
| % Growth | -4.6% | -21% | -18.6% | – |
| Cost of Goods Sold | $28,714 | $28,752 | $42,597 | $42,470 |
| Gross Profit | $21,480 | $23,859 | $24,038 | $39,366 |
| % Margin | 42.8% | 45.3% | 36.1% | 48.1% |
| R&D Expenses | $1,345 | $1,823 | $1,518 | $1,378 |
| G&A Expenses | $0 | $19,680 | $23,177 | $17,709 |
| SG&A Expenses | $13,676 | $17,880 | $23,177 | $17,709 |
| Sales & Mktg Exp. | $0 | -$1,800 | $0 | $0 |
| Other Operating Expenses | $0 | $2,075 | -$919 | -$90 |
| Operating Expenses | $15,021 | $21,778 | $22,258 | $17,619 |
| Operating Income | $6,459 | $2,081 | $1,911 | $21,747 |
| % Margin | 12.9% | 4% | 2.9% | 26.6% |
| Other Income/Exp. Net | -$196 | $50 | -$10,853 | -$312 |
| Pre-Tax Income | $6,263 | $2,131 | -$8,942 | $21,435 |
| Tax Expense | -$314 | -$600 | $634 | $5,277 |
| Net Income | $6,242 | $2,352 | -$9,576 | $15,851 |
| % Margin | 12.4% | 4.5% | -14.4% | 19.4% |
| EPS | 0.014 | 0.005 | -0.021 | 0.035 |
| % Growth | 165.4% | 124.9% | -160.2% | – |
| EPS Diluted | 0.014 | 0.005 | -0.021 | 0.034 |
| Weighted Avg Shares Out | 453,731 | 454,105 | 457,180 | 457,001 |
| Weighted Avg Shares Out Dil | 453,731 | 454,105 | 457,180 | 460,957 |
| Supplemental Information | – | – | – | – |
| Interest Income | $174 | $125 | $131 | $45 |
| Interest Expense | $171 | $75 | $102 | $357 |
| Depreciation & Amortization | $4,724 | $5,472 | $6,658 | $5,885 |
| EBITDA | $11,158 | $7,678 | -$2,182 | $27,388 |
| % Margin | 22.2% | 14.6% | -3.3% | 33.5% |